The generation of cytotoxic T cell epitopes and their generation for cancer immunotherapy Kessler, J.
9
0
0
Hele tekst
(2) CV & PUBLICATIONS.
(3) SNOITACILBUP & VC.
(4) Curriculum vitae
(5) !
(6) " #
(7) $ $
(8) %
(9) $ &'
(10)
(11)
(12) $ & ( ) * $ $) % $ % + ,$
(13)
(14) ) .% /
(15)
(16)
(17)
(18)
(19) $ %
(20) / $
(21) 0
(22)
(23)
(24)
(25) 1.% %
(26) !
(27) / .%!2" * )
(28) 34 % $ 5 $
(29) 3 $
(30)
(31) $ 1.%!2/
(32)
(33) 67
(34)
(35)
(36) %
(37) ! $ $ %
(38) * $
(39)
(40) $
(41)
(42)
(43)
(44) % *
(45) 1*2 !
(46)
(47)
(48)
(49)
(50) %
(51) 8
(52) , " 9 6 $) van de afdeling Immunohematologie en Bloedtransfusie aan het LUMC te Leiden wat heeft gere $ $ " ; <446 $ $)
(53)
(54)
(55) =
(56) > ?
(57)
(58) >
(59)
(60) 7
(61) $
(62) /
(63)
(64) $) %
(65)
(66) ".
(67)
(68)
(69) .
(70) Publications =
(71) A*/ D /
(72) =
(73) " " *
(74)
(75) 7
(76) $
(77) $
(78) , $ "
(79)
(80) =
(81) A*/ D /
(82) =
(83) " " *
(84) , $
(85)
(86)
(87)
(88) *
(89) EF*
(90) 7 /
(91) ,
(92)
(93) $" D/ A* =
(94) / G= H/
(95) =
(96) " 2007" *
(97) % J
(98) ,
(99) 7 %
(100)
(101)
(102) % $ %
(103) $
(104)
(105) , "
(106)
(107) D
(108) = = " 2007" ; 8
(109) K7
(110) $
(111) ,"
(112)
(113) !!" D/ 9! * 7
(114) / ! %
(115) / ! H/ ; D) / =
(116) / ! = / H '0
(117) / & N)O / '
(118) / A ' /
(119) = = " 2006" *H7!*
(120)
(121)
(122) 7 8 N@1P2 K7 "
(123)
(124) " !" GJ =/ D / = * $/ H! %
(125) 9 / Q %
(126) = / #
(127) / 9D %
(128) * / =
(129) / ; 9$ / D A
(130) / 9 '
(131) /
(132) = = " 2006" N
(133)
(134)
(135)
(136) , N@P K 8 H!=Q+
(137)
(138) K7 $
(139) ," Clin Cancer Res 12: 31303136. D/ &Q * $) / K = / = = / 9D %
(140) * /
(141) & N)O " 2004" 7
(142)
(143)
(144)
(145) , D!
(146) ;" Curr Protoc Immunol Chapter 18: Unit 17. D/ * =
(147)
(148) / K = / ; D) / N / &Q * $) / G= 9$ / H '0
(149) / Q G,/ = = / 9D %
(150) * /
(151) & N)O " 2003" 7
(152)
(153)
(154)
(155) , R %
(156) D!
(157) ;
(158) S 7
(159) , $ " Hum Immunol. 64: 245-255. D/ # *
(160) / 9! * 7
(161) / ) / ! %
(162) / !=
(163) 7 / N. / G *$/ =G / ! 9) / & N)O / A ' / H '0
(164) /
(165) = = " 2001" QJ 8
(166) % D!7!1T24<47 , E K , $, $ , E
(167) H!=Q ,
(168) 7
(169)
(170)
(171) ," J Exp #
(172) $ " !!
(173) '/ D / ; D) / G *$/
(174) = = " 2000" *H7!* $
(175) ,+
(176) %
(177)
(178) ,V
(179) % & ! "! *$ G/ D / != / !! * 7
(180) / ! G / * G $ / %
(181) * / = = /
(182) '
(183) " " ! *H7!* <4 *<!< W > , D!7NH<
(184) , E K , $,
(185) , D!7NH
(186) $
(187) $
(188) ;1<
(189) <2 " '($ ! *$ G/ D / */ != / G
(190)
(191) 7
(192) / = = /
(193) '
(194) " !" *H7!* E ,
(195) =
(196)
(197)
(198)
(199) $
(200)
(201)
(202) $ $,
(203) " ' ) *
(204) ( *$ G!/ != / D / = = /
(205) '
(206) " +" H *H7!* positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a *H7!*
(207) " Blood 88: 3522-3527.. / / !Q * / N H/
(208) ! $ % " " D , A
(209)
(210) H %
(211) ,
(212) <P $
(213) $" ) '( &
(214) " +"+". / D D / H 9$ > / ; ;
(215)
(216) / /
(217) / N H/
(218) !. $ % " "" K, $ $,
(219) 7
(220) %
(221) $ $
(222) , R7
(223)
(224)
(225) <P7
(226) , A
(227)
(228) 7 $
(229) $" '&
(230) ) , / !" @4
(231)
(232)
(233) .
(234) NAWOORD.
(235) DROOWAN.
(236) Nawoord.
(237)
(238) 6/ )
(239) / % %
(240)
(241) ;D*" ( $
(242) % " N
(243) >)
(244)
(245)
(246) %
(247)
(248)
(249) $ 0 $
(250) % / ) %
(251) / $
(252)
(253) $
(254)
(255) " N
(256)
(257) $
(258)
(259) % )
(260)
(261)
(262) % > "
(263) & / )
(264) )
(265) )
(266) )
(267) $ $ $ >/ "
(268) " ) )
(269)
(270) /
(271)
(272)
(273) " .
(274)
(275)
(276) % % %
(277)
(278) + & / / ! / <
(279) N)O \ )
(280)
(281) " A ,/ plementatie van de door jou opgezette proteasome-digestie analyse in mijn project heeft het epitope 8
(282)
(283) % $ % % $
(284) " !/
(285)
(286)
(287) ,
(288)
(289) "
(290) % ) $ $ )
(291)
(292) %
(293)
(294) )% %
(295) $ " *%
(296) ) > % $ =97
(297)
(298) $
(299) % % " 9
(300) / ) )
(301) $
(302) ) $ $ " =
(303) G/ $
(304) ) ) H!=Q7 $ " N
(305)
(306) ;% D) /
(307) . ) / N , #
(308) $ > / %
(309)
(310) / $ $ % " *% / #
(311) / $ ) =
(312) / =
(313) )/ H >
(314) 9, ) !;'3 $ 8 ) ] ) 8 %
(315)
(316) %
(317) >
(318) " 9,
(319) % ) ;N " D %
(320) )
(321) $
(322)
(323) 3" . >
(324) \
(325) S \ ! + $
(326) % ) S
(327) % >
(328)
(329) ) S " ;D*7 +
(330) )
(331) %
(332) ;
(333) ^% (/ Q G/ ! A
(334)
(335) ) "
(336) / % /
(337) ) %
(338) >>3 > $ " ;
(339)
(340)
(341) / ! + $
(342)
(343) K >3 $ _
(344) >) )
(345) % > / >
(346)
(347)
(348)
(349)
(350)
(351)
(352) / `
(353) )
(354) q" !
(355) $
(356) + H /
(357) ) / " D $
(358)
(359) / =
(360)
(361) V 9
(362)
(363) / )
(364) % > ) 7
(365) $ / 3 )) x $ " 9
(366)
(367) */ )
(368)
(369)
(370) % 7
(371) % " =
(372)
(373) %
(374) ) %
(375)
(376)
(377) 5 ) > $
(378) % "
(379) S
(380) +
(381)
(382) A
(383) >
(384) /
(385) >
(386) $ $
(387)
(388) ) % " K / /
(389)
(390) $ >
(391) $ % +
(392) 5 $ 3 \ $
(393)
(394) %
(395) / >
(396) $ $ ". 1 E72K7 7K7 $ $ % {{
(397) )
(398) % $ F
(399)
(400) " K
(401)
(402) /
(403)
(404)
(405) K7 + Q $ / D / =
(406) ) 12/ G ) x
(407) x ! 1 $ 5
(408) 7
(409) 3/ 2/ H /
(410) / K$
(411) x Q | x 9)
(412)
(413) # 1%
(414) K!
(415) 2/
(416) %9 x D '/
(417) W,/ '/ # */ ; / ,/ $ x
(418) 1
(419)
(420) % F
(421) + 2/ 9
(422) 1
(423) )
(424) 2/ K
(425)
(426)
(427) / G 1 $
(428) $2/ 9) / =
(429) } / A
(430) / 9>
(431) / =
(432) )/ # / A
(433)
(434) $
(435) / N / !$/ / !) / =
(436) / * 1% 8
(437) }2/ ! A x x. / Q 1 <42/ H x =
(438) / N
(439)
(440) 1 > $ ) 2/ * ) =/ K
(441) =/ G)/ $
(442) / H
(443) / =$ / =)
(444) D/ #
(445) $
(446) Q $ ~ A
(447) ,/
(448) . 9 * ) =
(449) $ 9 1 E 2
(450)
(451)
(452) % $ /
(453)
(454) $ % $
(455) )
(456)
(457) " Leiden, 10 september 2009 #
(458) @R.
(459)
(460)
GERELATEERDE DOCUMENTEN
Other peptidases liberating the C-terminus of $ 7 X such peptidases, we began an in-depth investigation of the generation of a CTL epitope with an
#$" / # * $" * & >?:@A QR >< ?:RQ2R' =& nardilysin-dependent CTL epitopes may also be over-expressed in cells that are treated with / >2 / insensitive
Ook al laat de natuurlijke afweer tegen kanker het afweten, deze valt wel op te wekken met 3 %& $= 4 & % " 1 / &&0 3 ook nog het co-stimulatie signaal in de
2 De vraag is niet of een cytosolisch peptidase bijdraagt aan enerzijds de afbraak van potentiële HLA klasse I-gepresenteerde peptiden óf anderzijds de vorming van
Since expression of Serpins may facilitate the immune escape of HLA positive tumors, we next analysed the effect of Serpin expression on survival in cases with normal/partial
Peripheral blood cells were stained with HLA-A2.1 tetramers containing the tyrosinase368–376 peptide followed by staining with a panel of lineage antibodies, as described in
Blades and blade fragments seem to have been especially used for longitudinal motions, mainly on plant material (7/12). Flake and flake fragments are used in different motions on
This shape also occurs in the combination artefacts (see below). The shape is the result of intensive use in a repetitive abrasive motion, carried out from different angles. In
